|
|
|
|
The GlobalSurg 3 REDCap database is now finally locked – no further data entry or editing is possible.
The data analysis team are now completing final data cleaning – this includes removing incomplete data, any duplicate patients and those that did not meet the inclusion criteria.
Thanks to everyone’s extra efforts adding missing data and checking key variables, the data is of higher quality than any of our previous studies and very few patients and teams have had to be removed on account of incomplete datasets.
The results are going to offer unique insights into quality and outcomes of cancer surgery on a truly global scale – something that has never been achieved on this scale before.
We’re looking forward to sharing the results with you as soon as we can – and to publishing the study in a high impact medical journal!
Validation stages 1 & 2 are also now closed to data entry.
80% of registered validators completed both stages 1 & 2.
The effort all teams put into ensuring their data was complete prior to validation commencing has ensured GlobalSurg 3 is our highest quality dataset yet – but crucially the work of our team of validators demonstrates this quality in a rigorous, scientific manner. This level of quality assurance within the dataset will be vitally important in demonstrating to our readers that the reported results are valid.
Incomplete validation is not a reason for removal from the primary analysis – those hospitals where a validator was not recruited or the registered validator did not complete stages 1 & 2 will still be included.
Validation – Hospital Level Survey
We’ve had a fantastic response to the GlobalSurg 3 Hospital level survey – over 150 completed responses have already been submitted by our team of validators.
This is allowing us to gather crucial information relating to cancer surgery service provision at the hospital level. Collecting data on the current provision is the first step to improving access to better cancer surgical care for all patients.
We are now contacting teams at some hospitals without a registered validator and inviting them to take part. Only a single response per hospital is required so not all teams will be contacted.
Part of the Hospital Level Survey involves the collection of photographs of GlobalSurg hospitals, operating tables and anaesthetic machines. We’re particularly excited about this part of the project, as we’re collaborating with the GapMinder Foundation and hope GlobalSurg hospitals will feature in a new area of their Dollar Street initiative.
|
|
|
Have you got a topic you’d like us to feature in a podcast? Would you like to join us to record a podcast about your experience of taking part in a GlobalSurg study? Email us on [email protected] – we’d love to hear from you!
|
|
|
The NIHR Global Health Research Unit on Global Surgery was established as a consortium between UK partners, The Universities of Birmingham, Edinburgh & Warwick, and international GlobalSurg partner institutes in LMIC.
We’re delighted that research hubs are now established and active in Mexico, South Africa, Nigeria, Rwanda & Ghana.
You can read more about the NIHR Global Surgery unit here
Selected hospitals in hub countries will be conducting international surgical randomised controlled trials.
The FALCON trial is already actively recruiting in Mexico, India and Rwanda and this week randomised it’s 100th patient!
Over the coming years more trials will open testing interventions to improve outcomes for surgical patients all around the world.
|
|
|
|
|
|
Following on from this success, the group is now running a research prioritisation exercise to identify priorities in research on OesophagoGastric anastomotic leaks. The results of this exercise will inform the selection of the OGAA group’s next study. The group would be very grateful for any surgeons (trainee or senior surgeon) who have performed oesophagectomy to please participate in the exercise (https://is.gd/ogaadelphi).
The deadline for participation is 26 July 2019
|
|
|
|
|
|
|
|
Leave A Comment